MR编号 | NL/H/1859/005 |
---|
药品名称 | Belfor HCT 40 mg/10 mg/25 mg |
---|
活性成分 | - Amlodipine besilate 10.0 mg
- Hydrochlorothiazide 25.0 mg
- Olmesartan medoxomil 40.0 mg
|
---|
剂型 | Film-coated tablet |
---|
上市许可持有人 | Menarini International O.L. S.A.
1, Avenue de la Gare
L-1611 Luxembourg |
---|
参考成员国 - 产品名称 | Netherlands (NL) Belfor HCT |
---|
互认成员国 - 产品名称 | - Italy (IT)
- Germany (DE)
Vocado HCT 40 mg/10 mg/25 mg Filmtabletten - Belgium (BE)
- Luxembourg (LU)
- Ireland (IE)
- Austria (AT)
Amelior plus HCT 40 mg/10 mg/25 mg Filmtabletten - Spain (ES)
- Portugal (PT)
- Greece (GR)
- Hungary (HU)
DUACTAN HCT 40 mg/10 mg/25 mg filmtabletta - Poland (PL)
Elestar HCT - Slovakia (SK)
Folgan HCT 40 mg/10 mg/25 mg - Slovenia (SI)
- Romania (RO)
Inovum HCT 40 mg/10 mg/25 mg, comprimate filmate - Bulgaria (BG)
Tespadan HCT - Cyprus (CY)
ORIZAL PLUS 40mg/10mg/25mg FC TABS - Estonia (EE)
SANORAL HCT - Latvia (LV)
- Lithuania (LT)
Sanoral HCT 40 mg/10 mg/25 mg plėvele dengtos tabletės - Malta (MT)
|
---|
许可日期 | 2010/12/02 |
---|
最近更新日期 | 2025/01/29 |
---|
药物ATC编码 | - C09D ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS
|
---|
申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Additional Strength/Form
- TypeLevel3:Fixed combination Art 10b Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|